Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification.
Journal:
Health Aff (Millwood)
41(10):1423-1432
Publish Date:
2022-10-01
Author Profiles:
Post-Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004-2014.
Journal:
Clin Pharmacol Ther
112(4):846-852
Publish Date:
2022-10-01
Author Profiles:
Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
Journal:
Genet Med
24(10):2014-2027
Publish Date:
2022-10-01
Author Profiles:
Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies.
Journal:
Br J Haematol
199(1):100-105
Publish Date:
2022-10-01
Author Profiles:
Virtual frailty assessment for older adults with hematologic malignancies.
Journal:
Blood Adv
6(18):5360-5363
Publish Date:
2022-09-27
Author Profiles:
Ethics Consultation in Oncology: The Search for Quality in Quantity.
Journal:
JCO Oncol Pract
18(9):610-613
Publish Date:
2022-09-01
Author Profiles:
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia.
Journal:
JCO Oncol Pract
18(9):e1522-e1532
Publish Date:
2022-09-01
Author Profiles:
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD.
Journal:
Nat Biotechnol
40(9):1319-1325
Publish Date:
2022-09-01
Author Profiles:
Very Low Rates of Ureteral Injury in Laparoscopic Hysterectomy Performed by Fellowship-trained Minimally Invasive Gynecologic Surgeons.
Journal:
J Minim Invasive Gynecol
29(9):1099-1103
Publish Date:
2022-09-01
Author Profiles:
Ethics Consultation in Oncology: The Search for Quality in Quantity.
Journal:
JCO Oncol Pract
18(9):610-613
Publish Date:
2022-09-01
Author Profiles: